MARKHAM, ON, July 12, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), today announced that it has entered into a Memorandum of Understanding ("MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to supply the Province with high quality adult recreational-use cannabis products.

Under the terms of the MOU, MedReleaf has agreed to supply the BCLDB with cannabis products in a variety of formats including dried flower and capsules. MedReleaf will be represented on British Columbia's on-line and brick and mortar retail outlets under the San Rafael '71, AltaVie and Woodstock brands.

San Rafael '71 is inspired by and designed to celebrate the spirit of classic cannabis culture, aimed at discerning adults who are knowledgeable about cannabis products and who value quality and an authentic experience. AltaVie is designed for a premium consumer and those new to cannabis who are curious, selective and interested in general wellness and enrichment. Woodstock is an iconic brand and a trusted symbol of the lifestyles of the cannabis community; bringing to market quality products that embody the values of Woodstock.

"Partnering with the BC Liquor Distribution Branch in supplying adult recreational cannabis is a valuable opportunity for MedReleaf to expand our footprint across Canada," said Neil Closner, CEO of MedReleaf. "With an annual production capacity that will approach 140,000 kilograms, we are well equipped to meet the anticipated high demand that discerning BC consumers will have for the premium quality cannabis products that MedReleaf has become recognized for across Canada."

As Canada's leading supplier of premium medical and recreational cannabis, MedReleaf is recognized for its commitment to cultivating consistent, safe, high-quality cannabis. That same exceptional quality is applied to the cultivation and production of all recreational cannabis products. At the voter-driven 2017 Lift Canadian Cannabis Awards, MedReleaf led the industry by winning LP of the year and placing in 10 different categories including first place awards in several product categories: Top Indica Flower, Top CBD Flower, Top High THC Flower, and Top High CBD Oil.

About MedReleaf Corp.

Canada's most awarded licensed producer, MedReleaf is an R&D-driven company dedicated to innovation, operational excellence and the production of top-quality cannabis. Sourced from around the world and carefully cultivated in one of two state-of-the-art ICH-GMP and ISO 9001 certified facilities in Ontario Canada, with a third facility currently in development, premium MedReleaf products are delivered to the global medical market. MedReleaf serves the therapeutic needs of patients seeking safe, consistent and effective medical cannabis and provides a compelling product offering for the adult-use recreational consumer.

For more information on MedReleaf, its products, research and how the company is helping patients #livefree, please visit MedReleaf.com or follow @medreleaf

SOURCE MedReleaf Corp.

For further information: Denise Riposati, Corporate Communications, [email protected], 289-317-1000 ext. 1118; Dennis Fong, Investor Relations, [email protected], 416-283-9930

Related Links

www.medreleaf.com

